Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey
Discussion Contrary to previous studies, our results showed a low number
of infections and mortality in SARS-CoV-2-positive psychiatric patients. Several
preventive measures seem effective to protect this vulnerable group. Our
observations are compatible with the hypothesis of a protective effect of
psychotropic drugs against COVID-19 as the overall mortality and need for
specific medical treatment was low. [...] Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: Pharmacopsychiatry - Category: Psychiatry Authors: Mueller, Juliane K. Ahrens, Kira F. Bauer, Michael Baune, Bernhard T. Borgwardt, Stefan Deckert, J ürgen Domschke, Katharina Ellwanger, Regina Fallgatter, Andreas Frodl, Thomas Gallinat, J ürgen Gottschalk, Ren é Grabe, Hans J Hasan, Alkomiet Herpertz, Tags: Original Paper Source Type: research
More News: COVID-19 | Germany Health | Hospitals | Intensive Care | Men | Mirtazapine | Psychiatry | SARS | Study